Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Clinical trial NCT01562574 · COMPLETED

Trial details

NCT number: NCT01562574
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass

Start date: 2002-01-01
Primary completion: 2004-08-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.